R207910

	WikiDoc Resources for R207910
Articles
Most recent articles on R207910 Most cited articles on R207910 Review articles on R207910 Articles on R207910 in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on R207910 Images of R207910 Photos of R207910 Podcasts & MP3s on R207910 Videos on R207910
Evidence Based Medicine
Cochrane Collaboration on R207910 Bandolier on R207910 TRIP on R207910
Clinical Trials
Ongoing Trials on R207910 at Clinical Trials.gov Trial results on R207910 Clinical Trials on R207910 at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on R207910 NICE Guidance on R207910 NHS PRODIGY Guidance FDA on R207910 CDC on R207910
Books
Books on R207910
News
R207910 in the news Be alerted to news on R207910 News trends on R207910
Commentary
Blogs on R207910
Definitions
Definitions of R207910
Patient Resources / Community
Patient resources on R207910 Discussion groups on R207910 Patient Handouts on R207910 Directions to Hospitals Treating R207910 Risk calculators and risk factors for R207910
Healthcare Provider Resources
Symptoms of R207910 Causes & Risk Factors for R207910 Diagnostic studies for R207910 Treatment of R207910
Continuing Medical Education (CME)
CME Programs on R207910
International
R207910 en Espanol R207910 en Francais
Business
R207910 in the Marketplace Patents on R207910
Experimental / Informatics
List of terms related to R207910

R207910 is an experimental anti-tuberculosis drug.^[1]

References

↑ de Jonge MR, Koymans LH, Guillemont JE, Koul A, Andries K (2007). "A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910". Proteins. 67 (4): 971–80. doi:10.1002/prot.21376. PMID 17387738.